China News Service, Guangzhou, November 14 (Reporter Cai Minjie) The 3rd China Respiratory Health Conference kicked off in Guangzhou on the 14th. Zhong Nanshan, academician of the Chinese Academy of Engineering, released the "Top Ten Annual Progress in National Respiratory Health in 2025‑2026".
The progress release selection adopts a workflow of intelligent search, multi-core unit expert voting, and national consensus. The selected results are all led by domestic scholars and cover multiple dimensions such as clinical research, guideline consensus, new drug research and development, and public health prevention and control. They include international multi-center research on bronchiectasis, exploration of COPD prevention and control systems, grassroots antibiotic intervention RCT research, lung cancer targeted therapy clinical trials, and pulmonary nodule AI evaluation systems. A number of original results with international influence.
"We look forward to more high-quality traditional Chinese medicine research being selected into the top ten progress next year, further demonstrating the disciplinary value of synergy between traditional Chinese and Western medicine," he said.
Ran Pixin, deputy director of Guangzhou National Laboratory, pointed out that lung cancer, chronic obstructive pulmonary disease, and respiratory infectious diseases are still major public health challenges. Guangzhou National Laboratory continues to focus on the early prevention and early treatment of chronic respiratory diseases and the research and development of new drugs and vaccines, and has achieved landmark results. However, to build a comprehensive Chinese program for the prevention and treatment of respiratory diseases, gain widespread international recognition, and implement it to benefit the people, colleagues in the industry still need to continue to overcome difficulties.
Zhang Junhua, a professor at Tianjin University of Chinese Medicine, read out the congratulatory letter from Zhang Boli, an academician of the Chinese Academy of Engineering, on the spot, and released the "2026 Evidence-Based Research Report on the Prevention and Treatment of Respiratory Diseases with Traditional Chinese Medicine." The congratulatory letter pointed out that the synergy of traditional Chinese and Western medicine is not a simple superposition, but complementary advantages and deep integration under a unified diagnosis and treatment framework. It is necessary to rely on scientific and technological innovation to tap the treasure house of traditional Chinese medicine and contribute Chinese wisdom to protecting the people's respiratory health. The report systematically sorts out the multi-dimensional research results of domestic traditional Chinese medicine in the field of respiratory diseases, including basic mechanisms, clinical compounding, and creation of new traditional Chinese medicines, and provides reference for the evidence-based development of traditional Chinese medicine in the field of respiratory diseases.
This opening ceremony has 12 launching, releasing and awarding ceremonies. "Traditional Chinese and Western Medicine Collaborative Respiratory Health Development Community and Respiratory Health Medical Clinic Training Activities" was launched. The community was jointly initiated by the National Center for Respiratory Medicine, the Haihe Laboratory of Modern Chinese Medicine, the First Affiliated Hospital of Guangzhou Medical University, and many pharmaceutical industry units. It brings together the forces of industry, academia, and research, focuses on respiratory disease prevention, diagnosis and treatment, science popularization, and full-cycle management, and promotes the in-depth integrated development of traditional Chinese and Western medicine.
The "Respiratory Health Ten Thousand Medical Clinics" grassroots training project launched simultaneously will empower grassroots workers at second and third terminals with standardized online courses and promote high-quality respiratory medical resources to reach the grassroots.
In addition, the conference simultaneously held a series of important activities such as the release of multiple academic monographs, the launch of the preparation of expert consensus, and the launch of clinical research on innovative drugs, covering multiple directions such as the compilation of academic works, clinical research on new drugs, artificial intelligence medical applications, disciplinary talent cultivation, technology alliance construction, and standardized construction of lung function quality control.
